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Abstract 
 
Little research has explored the relationship between characteristics of 
psychopathy and assessments of impulsive behavior using laboratory behavioral 
measures. The current study examined impulsive decision-making (delay discounting, 
DD) and disinhibition in relation to ratings of psychopathy in a sample of adolescent 
smokers (n = 30) and nonsmokers (n = 15). Smokers and nonsmokers did not differ 
significantly in ratings of psychopathy or on the measure of disinhibition. However, 
smokers and nonsmokers did differ significantly on the measure of DD, with smokers 
discounting more impulsively than the nonsmokers. For a second set of analyses, smokers 
were subdivided into high and low psychopathy groups (n = 15 each) based on a median 
split. These groups were compared against each other and the nonsmokers. The three 
groups did not differ on the measure of disinhibition. For the measure of DD, the low 
psychopathy smokers and nonsmokers still differed as described above for smokers and 
nonsmokers; however, the high psychopathy smokers did not differ from the nonsmokers. 
Also, there was a negative correlation between the measures of DD and psychopathy, 
indicating that participants with higher psychopathy ratings on average discounted less 
(i.e., performed less impulsively) than participants with lower ratings. These findings 
indicate that being high in characteristics of psychopathy (e.g., grandiosity or 
callousness) reduces, or offsets, the relationship between DD and smoking status among 
adolescents. These findings may shed light on specific behavioral characteristics (i.e., 
psychopathy) that influence the relationship between delay discounting and cigarette 
smoking status. 
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Impulsivity and Psychopathy in Adolescent Smokers and Nonsmokers 
In contemporary times, the concept of psychopathy has received increasing 
attention. The media reports many shocking cases of extreme violence and cruelty. Social 
science researchers have tried to identify psychopathic traits, and one characteristic that 
stands out is the construct of impulsivity. Impulsive behavior may represent the hallmark 
behavioral characteristic of psychopathy (American Psychiatric Association, Diagnostic 
and Statistical Manual of Mental Disorders; 4th ed. text revision). Substance use 
disorders frequently co-occur with psychopathy, perhaps because of characteristics 
shared between these conditions such as low self-discipline, inabilities to control one’s 
behavior, or weak executive functions (Loney, Taylor, Butler, and Iacono, 2007).   
 The overall goal of this project was to explore relations between different 
dimensions of impulsivity and ratings of psychopathy in adolescent cigarette smokers and 
nonsmokers. To date, there has been a lack of research concerning psychopathy and 
impulsivity in adolescent populations. We expected that there would be an association 
between measures of impulsivity and ratings of psychopathy. We also anticipated that 
adolescents who smoked cigarettes would have higher ratings of psychopathy than 
adolescents who did not smoke. Such findings would parallel a finding from similar 
research with adults (Petry, 2002). 
 
 Impulsivity 
Impulsivity is a complex and multidimensional concept that is assessed through 
the use of both self-report questionnaires and laboratory-behavioral tasks (e.g. Reynolds, 
Ortengren, Richards, & de Wit, 2006). One of the distinctions between self-report and 
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laboratory-behavioral assessments is the fact that each examines impulsivity at different 
levels of specificity. Self-reports are the most commonly reported assessments of 
impulsivity, and they provide a more general characterization of behavioral styles (e.g. 
Reynolds, Patak, Schroff, Penfold, Melanko, & Duhig, 2007). These measures provide 
broad behavioral characteristics because they were designed to assess impulsivity as a set 
of general tendencies that have multiple factors that ultimately characterize a behavior as 
impulsive (Patton, Stanford, & Barratt, 1995). Some of these general tendencies may 
include traits like attention, self-restraint, perseverance, or mental stability. Some self-
reports have been developed for adolescent populations, and these versions have been 
found to be comparable with adult assessments (e.g. Fossati, Barratt, Acuarini, & Di 
Cegelie, 2002). 
Whereas self-reports assess broad dimensions of impulsivity, laboratory-
behavioral tasks examine more specific behaviors of interest. Laboratory-behavioral 
measures do not correlate well with self-report measures, and this may be the result of 
their examination of more specific behaviors (Reynolds et al, 2006). Related to 
impulsivity, these measures differ from self-reports in that they assess the actual behavior 
of interest. Laboratory-behavioral measures do not rely on the participant to accurately 
evaluate and disclose his or her own behavior. Therefore, these measures may provide 
more objective assessments of impulsivity (e.g. Dougherty, Mathias, Marsh, & Jagar, 
2005). 
Recent evidence indicates there are at least two types of impulsive behavior 
assessed with laboratory behavioral tasks: impulsive disinhibition and impulsive 
decision-making (Reynolds et al, 2006). Behavioral disinhibition is a model of impulsive 
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behavior involving the ability to hold back from performing certain behaviors (Logan, 
1994). For laboratory assessments, disinhibition is typically assessed with computerized 
reaction-time tasks that require subjects to initiate and then to hold back responses to 
certain images or sounds (Dougherty et al, 2003). These evaluations measure the 
participant’s capacity to restrain undesirable behaviors and responses. For instance, adult 
cocaine users were shown to have poor inhibition abilities compared to adults who did 
not use cocaine (Fillmore & Rush, 2002).  
The other dimension of impulsive behavior is impulsive decision-making. Delay 
discounting falls into this category and reflects the manner in which an outcome loses its 
ability to alter behavior because it is postponed (Rachlin, 2000). For example, if an 
individual is attempting to get in good physical shape, the ultimate value for fitness may 
be discounted because of the length of time it will take to reach the goal. With most 
laboratory measures of delay discounting, the comparative worth of immediate rewards 
against delayed rewards are measured with choice procedures (e.g. Richards, Zhang, 
Mitchell, & de Wit, 1999). More choices for an immediate, but smaller amount of money 
at the expense of the more valuable, but delayed amount of money is considered more 
impulsive. 
Considerable delay discounting research has focused on adult populations, 
especially adults with substance dependencies (Reynolds, 2006). Vuchinich and Simpson 
(1998) found that heavy drinkers discount more by delay than light drinkers, which may 
imply a direct relationship between this type of impulsivity and amount of alcohol 
consumed. In another study, self-reports of impulsivity were rated as higher for 
participants who were formerly drug-dependent than for participants who had no drug use 
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history; and this finding was confirmed with a delay discounting task (Allen, Moeller, 
Rhoades, & Cherek, 1998). A study by Petry (2001) examined the relationships among 
delay discounting, pathological gambling, and substance use disorders and found that 
pathological gamblers were more impulsive than non-gamblers. Also pathological 
gamblers with substance use disorders were more impulsive than gamblers without 
substance use disorders. This finding implies a possible additive interaction for these 
different conditions as related to impulsivity. Petry also reported a similar study in 2002 
that examined the associations among delay discounting, substance use, and antisocial 
personality disorders (ASP). This research found that substance abusers were more 
impulsive than non-abusers and that substance abusers with ASP were more impulsive 
than substance abusers without ASP. As already mentioned, one of the hallmarks of ASP 
is psychopathic characteristics. The interaction between ASP and substance abuse as 
related to impulsivity may again signify an additive relationship. However, there has not 
been any research to replicate these findings among adolescents high in characteristics of 
psychopathy, more specifically. 
 
Psychopathy 
Psychopathy is also a multi-faceted construct (Poythress, Dembo, Wareham, & 
Greenbaum, 2006) that is often measured through the use of self-report questionnaires 
(Farrington, 2005). Traits considered psychopathic include remorselessness, lying, lack 
of empathy, impulsiveness, and thrill-seeking; however, individuals may rate highly on 
only some of these characteristics. For example, a person may be rated highly on a 
measure of lying but be comparatively low on thrill-seeking behavior. However, the 
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individuals who are considered to exhibit the most psychopathy tend to rate highly on all 
or a majority of the psychopathic traits (Skeem & Cauffman, 2003). 
There has not been much research linking psychopathy and addiction (Smith & 
Newman, 1990). However, a few studies do indicate that psychopathic populations, in 
general, have higher rates of substance abuse than do non-psychopathic populations (e.g. 
Smith & Newman, 1990; Hart & Hare, 1989). A study by Reardon, Lang, and Patrick 
(2002) examined the relationship of psychopathic traits and alcohol problems and found 
that individuals who rated highest in psychopathy were more likely to have alcohol 
problems when compared against individuals with low ratings of psychopathy. Another 
study by Smith and Newman (1990) found that criminal offenders with high psychopathy 
ratings were more likely to meet DSM-III criteria for having drug-use disorders than were 
criminal offenders with low ratings of psychopathy. 
Recent investigations also have linked psychopathy with increased recidivism as 
well as treatment failures in forensic samples of adults (Poythress et al, 2006). In a study 
by Hart, Kropp, and Hare (1988) it was found that males who rated high on psychopathic 
traits were more likely to be rearrested one year after being paroled than male parolees 
who did not rate highly on psychopathic traits. Hare, Clark, Grann, and Thorton (2000) 
found that inmates with high psychopathy ratings often do not respond well to 
interventions and treatments of criminal behaviors. 
Findings in adults have influenced research with adolescent populations. Research 
has shown that many teens participate in some antisocial conduct but that these behaviors 
usually cease in late-adolescence (Lynam, Caspi, Moffitt, Loeber, & Stouthamer-Loeber, 
2007). However, a small subset of teens continue offending into adulthood (Skeem & 
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Cauffman, 2003). Psychopathy in adolescent populations has not received the same 
amount of attention as in adults (Salekin, Ziegler, Larrea, Anthony, & Bennett, 2003).   
Current measures of psychopathy serve to best distinguish adolescents who will 
desist their antisocial conduct and those who will maintain their conduct into adulthood 
(Poythress et al, 2006). If an individual can be identified early in life as exhibiting 
escalating psychopathic characteristics, steps can be developed to rehabilitate that 
individual before he or she reaches the point of persistent and possibly irreversible 
psychopathic conduct. For example, Hart and Hare (1997) found that adult criminal 
offenders who rate high in characteristics of psychopathy began to commit crimes at 
earlier ages than those offenders who did not rate as highly. Of further interest may be the 
notion that high ratings of psychopathy usually predict for poor treatment results (e.g. 
Hare et al, 2000). Perhaps identifying an individual as highly psychopathic may allow for 
the "tailoring" of a treatment regimen that best serves to rehabilitate that specific 
individual (Petry, 2002). 
This study was designed to consider the relationships between characteristics of 
psychopathy and impulsivity in adolescent smokers and nonsmokers. The study is an 
extension to adolescents of similar research in adults (Petry, 2002). Impulsivity was 
examined using two laboratory-behavioral procedures (behavioral disinhibition and delay 
discounting) and a self report questionnaire. It was hypothesized that the additive 
associations that Petry (2002) found between substance use and ASP in adults will 
replicate with adolescents. As such, there was expected to be additive effects of smoking 
status and psychopathy characteristics rating for impulsivity. 
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Method 
Participants 
Forty-five adolescents (approximately equal numbers of males and females) 
ranging between 13 and 17 years of age were recruited from a database maintained at 
Nationwide Children’s Hospital. These individuals had at some point in the past 
participated in research at Children’s Hospital and expressed interest in taking part in 
future projects. The participants were recruited on the basis of smoking status: 
nonsmokers (n = 15) (those who did not smoke cigarettes at all) and smokers (n = 30) 
(those smoking five to ten cigarettes per day). Smokers and nonsmokers were matched 
according to criteria such as race, sex, and median household income. Median household 
income was based on 2007 U.S. Census Tract data for Columbus, Ohio (U.S. Census 
Bureau, 2000). 
 
Dependent Measures 
 Question-based delay-discounting measure(DDQ; Richards et al, 1999). For this 
laboratory-behavioral task, subjects are given choices between $10 available after a delay 
(i.e., 1, 2, 30, 180, or 365 days) and a smaller amount which is immediately available 
(e.g., “Would you rather receive $10 in 180 days or $1 now?”). This measure follows an 
adjusting amount procedure (the immediate value adjusts in increments of ± $0.50) to 
determine an indifference point for each delay.  An indifference point is the monetary 
amount in which the delayed standard is equally likely to be chosen as an immediate 
choice that is of lesser value.  For example, a participant may reach an indifference point 
at receiving $.50 immediately versus $10 in 365 days. Choice questions are presented in a 
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random order. Subjects are told that their responses to the questions are important 
because at the conclusion of the DDQ session one question would be randomly selected, 
and the participant would receive the delayed or immediate money that was chosen. 
 Go-Stop task (Dougherty et al, 2003). This task is constructed to measure the 
ability to inhibit predominant, motor responses to visual stimuli. Subjects are shown a 
series of three-digit black numbers on a light grey computer screen (e.g., 740 . . . 614 . . . 
614 . . . 304) with a one second blank screen separating each three-digit number. Two-
hundred and forty of these trials were completed in two sessions of 120. Instructions were 
given to the participants to respond as quickly as possible by clicking the left mouse 
button when a matching three-digit number appeared (the go signal). The go signal was 
presented in 50% of the numbers. Subjects earned $0.05 for each go-signal response that 
happened during the 400ms while the three-digit number was visible. Five cents was lost 
for each late go-signal response that happened after the three-digit number disappeared 
from the screen (after 400 ms). The participant was penalized $0.10 for each click 
(response) to a non-matching number regardless of the latent period. A participant’s data 
were considered to be invalid for the task if 40% or more of the go-signal responses 
occurred late. This was taken to mean that the participant was not adequately responding 
to the go signal and in these instances, the data were removed from later analyses. 
 In 25% of the go-signal trials, the following matching number would change from 
black to red. This indicated a stop trial, and occurred randomly. Participants were told to 
withhold a left-click response when the three-digit number changed colors (the stop 
signal). Participants earned $0.05 for effectively withholding a click after the three-digit 
number changed colors. Five cents was lost for clicking at an improper time (i.e., clicking 
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after the matching number changed colors or clicking when the numbers did not match at 
all) . These color changes would occur at random times within the 400 ms of a go signal. 
The stop-signal intervals would vary as a function of performance, that is, becoming 
shorter following failures to inhibit a response and becoming longer following 
successfully stopping a response. Stop-signal time spans continue to regulate according to 
these rules until the subject is able to withhold the click response on approximately half 
of the stop-signal trials. At this 50% standard, the stop reaction time (RT) is analyzed by 
subtracting the stop-signal delay (when withholding a response is at 50%) from the go-
signal RT (the average interval for a subject to click to go-signals).  From this analysis, 
longer stop RTs reflect more behavioral disinhibition and therefore, more impulsivity. 
Both go RTs and stop RTs are measured in milliseconds. 
 Barratt Impulsiveness Scale 11 (Adolescent Version) (BIS-11-A; Fossati et al., 
2002). The BIS-11-A is a 30-item self-report questionnaire modified from an adult 
version (BIS-11) for use with adolescents (see Patton, Stanford, & Barratt, 1995). 
Analyses with the BIS-11-A present six first-order factors, which are as follows: Motor 
Impulsiveness, Cognitive Complexity, Self-Control, Lack of Delay, Attention, and 
Perseverance. Nevertheless, intercorrelations among these factors for teenagers are 
significantly higher than for factors of the BIS-11 for adults (Fossati et al., 2002). 
Accordingly, the BIS-11-A total score may be the best indicator of impulsivity for 
research with adolescents. Higher scores on the BIS-11-A indicate greater impulsivity. 
Youth Psychopathic Traits Inventory (YPI; Andershed, Kerr, Stattin, Levander, 
2002).  The YPI is a newly constructed self-report of psychopathy in adolescents. It 
consists of 50 items that measures psychopathic traits on a 4-point Likert-type scale (1 
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does not apply at all, 2 does not apply well, 3 applies fairly well, 4 applies very well).The 
50 items are equally distributed among ten sublevels that plot onto three domains: 
Grandiose-Manipulative (dishonest charm, grandiosity, lying, manipulation), Callous-
Unemotional (callousness, unemotionality, remorselessness), and Impulsive-Irresponsible 
(impulsivity, thrill-seeking, irresponsibility). An index score is taken from all domains to 
indicate the level of psychopathy, with higher YPI scores corresponding to greater 
characteristics of psychopathy. 
 
Procedure 
Before participating in the research, an informed consent was completed by a 
parent or legal guardian, and assent was obtained from the adolescent upon arrival at 
Children’s Hospital. All research was performed from 12:00 to 20:00 hours. 
Parents/guardians remained in a waiting room while breath and urine samples were 
collected from the participants for measurement of carbon monoxide (CO) and cotinine (a 
metabolite of nicotine) levels, respectively. Both the breath and urine samples allow for 
current smoking status to be determined. The breath sample was taken using a Micro 4 
Smokerlyzer (Bedfont Scientific, Kent, United Kingdon). Self-reported smokers were 
required to have a CO level of ≥ 9 ppm, and self-reported nonsmokers were required to 
have a CO level of ≤ 5 ppm. From the cotinine analyses smokers were required to have 
quantitative cotinine values ≥ 200 ng/ml. Nonsmokers had to have cotinine values of ≤ 50 
ng/ml. The urine sample was collected in a private restroom in a heat-sensitive cup to 
determine the temperature of the samples immediately after being obtained. 
Participants first completed an assessment of verbal and nonverbal ability 
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assessment using the Kaufman Brief Intelligence Test: Second Edition (2nd edition) 
(Kaufman & Kaufman, 2004). Next, self report measures were completed, and then 
participants received a five minute rest break.  Laboratory-behavioral measures were then 
completed. Task order was counterbalanced across all participants. Upon completion of 
all measures, participants were paid for their participation. Participant payment was 
partially calculated from performance on laboratory-behavioral tasks. 
 
Data Analyses 
 Participants were divided into three groups for comparison: (a) nonsmokers 
(n=15), who we expect to have low psychopathy ratings; (b) smokers, with low 
psychopathy ratings (n=15); and (c) smokers, with comparatively high psychopathy 
ratings (n=15). The smokers were divided into the low and high psychopathy groupings 
using a median split on psychopathy ratings. This allowed for the means of all three 
groups to be compared. 
An area-under-the-curve (AUC) method, described by Myerson, Green, and 
Warusawitharana (2001), was utilized to analyze data for the DDQ. Values of AUC are 
determined by graphing the indifference points from the participant’s responses on the 
DDQ and calculating the area under the discounting curve.  Using this method, smaller 
AUC values indicate greater discounting and impulsivity; and, conversely, larger AUC 
values indicate less discounting and less impulsivity. 
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Demographic data from smokers and nonsmokers were compared across groups 
with two-sample t-tests. However, categorical demographic variables such as race or 
gender were compared using Chi-squared testing. The data from delay discounting 
measures are not normally distributed and therefore nonparametric statistical techniques 
were used to analyze these data. Kruskal-Wallis H-tests were used to examine the results 
across the three groups. Significant effects were further analyzed by Man-Whitney U-
tests. Spearman’s correlation tests were performed on the various measures of impulsivity 
and psychopathy. 
All comparisons that did not involve delay discounting were made using separate 
one-way analyses of variance (ANOVAs). These analyses utilized participant 
smoking/psychopathy status as the grouping variables.  
  
Results 
Participant Demographics 
Participants self-reported demographic and drug use data are presented in Table 1. 
The smokers had significantly higher CO and cotinine levels than did nonsmokers, thus 
providing verification of smoking-status classifications. Smokers and nonsmokers also 
significantly differed in use of alcohol and marijuana. There were no significant 
differences between the groups’ use of caffeine. Smokers and nonsmokers’ KBIT scores 
were also significantly different which provide an estimate of IQ. 
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Table 1 
 
Participant Demographics and Drug Use Summaries 
________________________________________________________________________ 
           Smokers      Nonsmokers  
                                            ___________________________________________ 
 
 Variable  M  SD  M  SD    
________________________________________________________________________ 
Gender (n) 
 Male   11    7 
 Female   19    8 
 
Race (n) 
 White   16    7 
 Black   10    7 
 Other   4    1 
 
Annual Household  $56439 $25630 $65819 $29831 
Income (Mdn)a 
 
Age    15.9  0.80  15.06  1.099 
KBIT (Std Score)  100  12.8  87.4  13.4** 
Carbon Monoxide (ppm) 10.3  6.9  2.13  1.35*** 
Cotinine (ng/ml)  1510  725  31  29.9** 
 
Cigarettes   6.57  4.72  0.00  0.00*** 
(Number per day)b   
Alcohol c   2.08  1.47  0.07  0.63** 
Marijuana c   2.83  1.97  0.07  0.25*** 
Caffeine c   3.40  1.97  3.07  1.67 
________________________________________________________________________ 
Note.  N = 45. a The median household income was calculated based on average income from 
census tract data of the participant’s residence.  b Cigarettes per day were calculated using a 
timeline follow back calendar to determine cigarettes smoked each day during the past 30 days c 
Substance use was assessed with the following question: “Thinking about the past 6 months, how 
often have you used the following substances?”: 0 = never tried, 1 = tried it, 2 = 1-2 times/month, 
3 = once a week, 4 = 2-4 times/week, 5 = 5 or more times a week. 
* p < .05  ** p < .01   *** p <  .001. 
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Smokers were further divided into high and low psychopathy groups, and their 
respective self-reported demographic and drug use data are contained in Table 2. There 
were no significant differences between the high and low psychopathy smoking groups’ 
use of any drug. 
Table 2 
Participant Demographics and Drug Use Summaries for Smokers 
________________________________________________________________________ 
    High Psychopathy  Low Psychopathy  
                                          ____________________________________________ 
 Variable  M  SD  M  SD 
________________________________________________________________________
    
Gender (n) 
 Male   6    5 
 Female   9    10 
 
Race (n) 
 White   8    7 
 Black   6    5 
 Other   1    3 
 
Annual Household  $63084 $25873 $49785 $24423 
Income (Mdn)a 
 
Age    16  0.75  15.8  0.86 
KBIT (Std Score)  89  13.9  85.8  13.3  
Carbon Monoxide (ppm) 11.5  6.4  9.1  7.6 
Cotinine (ng/ml)  1597  888  1436  582 
 
Cigarettes   7.83  5.15  5.42  4.11 
(Number per day)b   
Alcohol c   2.33  1.59  1.73  1.33 
Marijuana c   3.53  1.81  2.13  1.88 
Caffeine c   3.33  2.09  3.46  1.92 
________________________________________________________________________ 
Note.  N = 45. a The median household income was calculated based on average income from 
census tract data of the participant’s residence.  b Cigarettes per day were calculated using a 
timeline follow back calendar to determine cigarettes smoked each day during the past 30 days c 
Substance use was assessed with the following question: “Thinking about the past 6 months, how 
often have you used the following substances?”: 0 = never tried, 1 = tried it, 2 = 1-2 times/month, 
3 = once a week, 4 = 2-4 times/week, 5 = 5 or more times a week. 
* p < .05  ** p < .01   *** p <  .001. 
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Dependent Measures 
 Psychopathy ratings for smokers and nonsmokers did not differ significantly, 
[F(1,44) = 1.58, p =.255, two-tailed test]. However, consistent with the initial hypotheses, 
there was a trend towards the smokers having higher psychopathy ratings than the 
nonsmokers (M = 54.17, SD = 22.24; M = 46.4, SD = 19.2, respectively) (see Figure 1 
below). 
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Figure 1:Psychopathy ratings of Smokers and Nonsmokers 
 
Smokers (M = 69.10, SD = 10.16) and nonsmokers (M = 68.33, SD = 10.45) also 
did not significantly differ on the BIS-11-A [F(1,44) = 0.002, p =.814, two-tailed test] 
(see Figure 2).  
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Figure 2: BIS-11-A Ratings of Smokers and Nonsmokers
 
Data from the Go-Stop Task for six smokers were omitted from analyses due to 
high percentages of late responses (see Methods section). Smokers and nonsmokers also 
did not significantly differ on the Go-Stop Task [F(1,44) = 0.032, p =.893, two-tailed 
test] (see Figure 3).  Smokers (M = 149.39, SD = 51.95) had a slightly lower average 
latency value than did nonsmokers (M = 151.87, SD = 58.18).  
Figure 3: Go-Stop Task with Smokers and Nonsmokers 
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Smokers and nonsmokers did significantly differ on the DDQ, [U(44) = 133.0, p = 0.027, 
two-tailed test] (see Figure 4). 
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Figure 4: DDQ Indifference Points Between Smokers and Nonsmokers 
From Table 1, the standard score measure of the KBIT-2 was also significantly 
different between smokers and nonsmokers. To test if these IQ differences account for 
the significant effect of smoking status on delay discounting, a binary logistic regression 
was performed in which IQ and delay discounting were jointly explored in relation to 
smoking status. This analysis allowed for exploration of unique or shared variance 
accounted for in smoking status by these two variables. As such, the effect of IQ 
remained significant (p = .035), while the effect of the DDQ was not found to be 
significant (p = .185). Therefore, it appears that IQ largely accounts for the same variance 
in smoking status as delay discounting. 
 As described before, the data from smokers were median split along ratings of 
psychopathy into a high and low psychopathy groups (M = 72.87, SD = 13.25; M = 35.57, 
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SD = 9.99, respectively). Again, demographics for these groups are presented in Table 2. 
Psychopathy ratings were significantly higher for the high psychopathy group than for the 
low psychopathy group [F(1,29) = 8.62, p = .000, two-tailed test]. Nonsmokers had 
higher psychopathy ratings than low psychopathy smokers (M = 46.40, SD = 19.16; M = 
35.57, SD = 35.47, respectively), but this difference only approached statistical 
significance [F(1,29) = 3.00, p = .060, two-tailed test]. 
Of the dependent measures, the DDQ was the only measure that significantly 
differentiated the three groups [H(44) = 9.38, p = .009, two-tailed test] (see Figure 5).  
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Figure 5: DDQ Indifference Points Among Nonsmokers, Smokers with 
High Psychopathy and Smokers with Low Psychopathy
High psychopathy smokers and low psychopathy smokers were found to be significantly 
different on the DDQ, [U(29) = 61.5, p = .034, two-tailed test]. This difference would not 
be accounted for by IQ as these groups did not significantly differ in IQ scores (see Table 
2). High psychopathy smokers and nonsmokers did not significantly differ on the DDQ, 
[U(29) = 91.5, p = 0.384, two-tailed test]. The DDQ did significantly differentiate the low 
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psychopathy smokers and nonsmokers [U(29) = 41.5, p = 0.003, two-tailed test]. Still, as 
with the comparison between smokers and nonsmokers, this difference was reduced to 
non-significance when variance accounted for by IQ was controlled (p = .117). 
On the basis that psychopathy carries with it an impulsive component, 
correlations were performed with the DDQ, total YPI, the three subfactors of the YPI 
(Grandiosity, Callousness, and Impulsivity), and the BIS-11-A. Correlations involving 
the DDQ required a Spearman’s rho correlation, and all other parametric variables 
utilized Pearson’s correlations. Total YPI score and the DDQ were significantly 
correlated, [rs(44) = -.30, p = .046, two-tailed test]. Among the subfactors of 
psychopathy, only the correlation between the DDQ with Grandiosity was significant, 
[rs(44) = -.31, p = .035, two-tailed test]. The correlation between DDQ and the subfactor 
of Callousness was not significant, but this relation approached significance [rs(44) = -
.28, p = .064, two-tailed test]. The relationship between the DDQ and the Impulsivity 
subfactor was not significant, [rs(44) = -.16, p = .28, two-tailed test]. This is possibly 
indicative of delay discounting not being the same construct of impulsivity as measured 
by the Impulsivity subscale of the YPI. The BIS-11-A was not significantly correlated 
with YPI total scores, thought this relationship approached significance [r(44) = .287, p = 
.056, two-tailed test]. However, the BIS-11-A was correlated with the Impulsive 
subfactor [r(44) = .54, p = .000, two-tailed test], but not with the other two subscales of 
Callousness and Grandiosity [r(44) = .063, p = .680, two-tailed test; r(44) = .131, p = 
.390, two-tailed test, respectively].  A low correlation (rs(44) = .14, p = .724, two-tailed 
test) between the BIS-11-A and the DDQ confirms the finding from Reynolds et al 
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(2006) that self report and laboratory-behavioral measures do not correlate well with one 
another. 
Discussion 
 This study assessed the relationship between impulsivity and psychopathy in 
adolescent cigarette smokers and nonsmokers. Several measures of impulsivity were 
utilized along with a self-report assessment of psychopathy. Smokers were rated slightly 
higher on the measure of psychopathy than nonsmokers; however, this difference was not 
significant. The hypothesis that smokers were more impulsive than nonsmokers on the 
self-report of impulsivity (BIS-11-A) was not confirmed. The measure of behavioral 
disinhibition (Go-Stop Task) also did not significantly differentiate smokers and 
nonsmokers. However, the measure of delay discounting (DDQ) did differentiate 
smokers and nonsmokers. The finding that smokers discount more than nonsmokers is 
consistent with the finding from Reynolds et al (2007) that smokers and nonsmokers 
would significantly differ on the DDQ. The same methodological considerations were 
observed in the current study in that smoking status was ascertained beyond self-reports 
(i.e., CO and cotinine analysis). However, when IQ differences between the smokers and 
nonsmokers were controlled, the smoking status difference in delay discounting was no 
longer significant. 
Upon performing a median split on smokers’ psychopathy scores, it was found 
that the DDQ significantly differentiated the low psychopathy group from the high 
psychopathy group and nonsmokers; but the DDQ did not distinguish between the high 
psychopathy group and nonsmokers. This finding indicates that the high psychopathy 
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group discounted similarly to nonsmokers - that being high in characteristics of 
psychopathy offset the drug-use differences regularly seen in delay discounting. 
When the YPI was divided into its component subscales it was found that the 
DDQ negatively correlated with the subscale related to Grandiosity/Manipulative and 
approached significance with the subscale of Callousness/Remorselessness. This negative 
correlation indicates that participants higher in these characteristics of psychopathy 
discount less by delay and therefore attend more to delayed outcomes. That is, 
individuals who rate highly in traits of manipulation and callousness are more future-
oriented than individuals who do not rate highly in these characteristics. It is often 
asserted that psychopathy is a “cold and calculating” disorder (Hare, 1993), and this 
finding with delay discounting may lend evidence to that claim. It is conceivable that an 
individual who lies to and manipulates others with dishonest charm would need to be 
more aware of temporal considerations in order to continue the exploitation of a victim 
over time. If the individual was not skilled in planning and directing his or her behavior 
toward long-term outcomes, then he or she would likely be exposed as fraudulent. 
The correlation between the DDQ and the Impulsive subscale of the YPI was low 
and not significant. This could indicate that the impulsive component of psychopathy is 
more related to “general” impulsive behavior and less to delay discounting. The 
significant correlation between the BIS-11-A and the Impulsive subfactor of the YPI 
confirms this suggestion. 
 It was hypothesized that the combination of high ratings of psychopathy and 
cigarette smoking would yield higher levels of impulsivity than would having low levels 
of psychopathy and smoking or nonsmoking.  This predicted additive relationship would 
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have paralleled earlier findings from Petry (2002); however, our findings did not confirm 
this hypothesis. This inconsistency between our findings and those of Petry (2002) may 
be the result of differences between the constructs of psychopathy and ASP.  Parallels 
between ASP and psychopathy are easily seen in their shared characteristics of 
deceitfulness (lying), irresponsibility, remorselessness, and general impulsivity; but ASP 
does not include any diagnostic criteria concerning psychopathy’s components related to 
a lack of emotions (e.g. manipulativeness, dishonest charm, grandiosity). 
Therefore, individuals with ASP may lack the future-oriented aptitudes of more 
exclusively psychopathic individuals. The fact that as many of 75 percent of prison 
inmates have a diagnosis of ASP (Moran & Mason, 2004), whereas 20 percent have high 
ratings of psychopathy, possibly indicate that the two constructs reflect two different 
syndromes (Hare, 1993). In the general population, it is estimated that one to three 
percent of the population fit the diagnostic criteria for ASP (DSM-IV-TR), whereas four 
to five percent could be diagnosed with clinical significant levels of psychopathy (Stout, 
2006). The fact that ASP (rather than psychopathy) is more prevalent in prison 
populations and psychopathy is more common (versus ASP) in the general population 
supports the above notion that there are important differences between these constructs. 
 A limitation of this study is the small sample size (n = 45). As was noted in the 
results section, several of the effects were not significant, but some did approach 
significance. It is possible that with a larger sample these effects would be significant.  
Another limitation is that adolescents were recruited from the general population and not 
recruited specifically for clinically significant levels of psychopathy. Given the small 
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sample size, further research to replicate the findings of this study between high ratings 
of psychopathy and adolescent cigarette-use on delay discounting is needed. 
Considering treatment implications for adolescent smoking, treatments oriented 
toward future, long-term outcomes may be more effective for individuals who rate highly 
on measures of psychopathy. It may be that people who are high in characteristics of 
psychopathy stand to better understand the long-term consequences of their actions and 
thus be more likely to regulate their behavior toward optimal long-term outcomes. 
In summary, this study provides evidence that adolescent smokers with high 
levels of psychopathy discount delayed rewards in a similar way to nonsmokers. That is, 
rating highly on characteristics of psychopathy appears to negate the frequently observed 
differences in delay discounting between drug users and nonusers (Reynolds, 2006). It 
may be that characteristics of psychopathy among adolescents describe a more 
temporally-aware behavioral style; and as such, a person who is more aware of the future 
may be more apt to make long-term goals and plans. As such, this study stresses the 
importance of examining factors associated with variability in delay discounting within 
drug-use groups. 
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Appendix A 
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH STUDY   
STUDY TITLE:  Correlates of Cigarette Smoking Status in Adolescents 
STUDY SPONSOR: Columbus Children’s Research Institute 
STUDY DOCTOR: Brady Reynolds, Ph.D. 
CONTACT TELEPHONE NUMBER:  614-722-3549 (24 hours a day, 7 days a 
week) 
 
SUBJECT’S NAME: ____________________ DATE OF BIRTH: 
_________________ 
 
NOTE:  The words “you” and “your” are used in this consent form.  These words refer to 
the study volunteer whether a child or an adult. 
 
1) INTRODUCTION 
We invite you to be in this research study.  Please learn enough about this 
research study, its risks and benefits, to decide whether you should agree to 
participate.  We must explain the study to you, and give you a chance to ask 
questions about anything you do not understand.  This process is called 
“informed consent”.  It is up to you to choose if you want to be in this study.  
You may refuse to be in this study or quit this study at any time, and standard 
medical care will still be available here or at a doctor of your choice without a 
penalty or loss of benefits to you. It is important to understand that there may 
not be any benefit from being in this study, but we may learn something that 
could help others. 
 
Before agreeing to participate, it is important to read and understand the study 
information in this consent form.  By signing the consent form, you agree to be 
in this study. If this study involves a child between 9 and 18 years of age, 
he/she must also agree to be in the study by signing an Assent form or on the 
assent line of this form.  You will be given a signed and dated copy of the 
consent and the assent form. 
 
2) WHY ARE WE DOING THIS RESEARCH STUDY? 
This study is intended to help us better understand risk factors related to smoking in 
adolescents.  It is expected that we will be able to identify some of the most 
influential risk factors of smoking cigarettes and use this information to develop 
better forms of treatment and prevention. 
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3) WHERE WILL THE STUDY BE DONE AND HOW MANY SUBJECTS WILL TAKE PART?  
This study will be done at Children’s Hospital. About 75 subjects will take part in this 
study.  All 75 subjects will participate here at Children’s Hospital. 
 
 
4) WHAT WILL HAPPEN DURING THE STUDY AND HOW LONG WILL IT LAST? 
The study involves a visit to the Children’s Hospital where the adolescent will 
participate in a 2 to 2.5 hour laboratory session. 
 
Teens will start by giving a urine and breath sample to test for cigarette smoking 
only. Cigarette-smoking status will be private and will not be shared. Then, teens will 
complete a learning, thinking, and problem-solving task of 30 minutes.  Following this 
task, teens will take a 5 minute break. After the break teens will spend about 35 
minutes completing twelve questionnaires, immediately followed by another 5 minute 
break. Some of these questionnaires ask questions about teens’ attitudes of 
cigarette smoking. Others ask questions about potentially illegal activities. The 
session will end after a five computer tasks and two interviews have been completed, 
which last about 1 hour. 
 
Teens will be reimbursed for this session based on computer-task performance 
(between $20 and $30 each).  These computer tasks offer the opportunity to earn 
money based on choices made during the tasks.  If the adolescent decides to quit 
the study before completing all of the computer tasks, he or she will get to keep 
whatever money had been earned to that point, with a minimum of $20.  $5 will be 
allotted for travel expenses.   
 
Session activities (2-2.5 hours): 
Teen: 
1. Give urine and breath samples (about 5 minutes). 
2. Complete learning, thinking and problem-solving tasks (about 30 minutes). 
3. Break (about 5 minutes). 
4. Complete paper questionnaires (about 35 minutes). 
5. Break (about 5 minutes). 
6. Complete computer tasks (about 1 hour). 
7. Reimbursement. 
 
 
5) WHAT BAD THINGS CAN POSSIBLY HAPPEN DURING THIS STUDY?  
Being in this study involves little risk to the subject.  All data will be coded with subject numbers so that the data will 
be separate from personally identifying information.  However, loss of confidentiality is possible but all steps will be 
taken to avoid loss of confidentiality. 
 
Some of the computer tasks may become boring, but the subject is able to withdraw from the study at anytime during 
the procedure.  The participant can keep whatever money had been earned to the point of quitting the study. 
 
There may be other risks of being in this research study, which are not known at this time. 
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6) WHAT GOOD THINGS CAN POSSIBLY HAPPEN DURING THIS STUDY?   
There may be no benefit from being in this study, but we might learn something that 
could help others.  
 
7) WHAT HAPPENS IF BEING IN THIS STUDY CAUSES INJURIES? 
If being in this study causes an injury, Children's Hospital will provide medical care.  
You or your insurance company may have to pay for the cost of this care. This does 
not mean that you give up any of your rights under state or federal laws to ask for this 
care to be paid by someone else. 
 
8) OTHER IMPORTANT INFORMATION 
 
Being in more than one research study at the same time may cause injury.  You 
should tell the Study Doctor about being in any other research study.  The Study 
Doctor will decide if it is OK to be in more than one study at the same time. 
 
 
9)   WHAT WILL HAPPEN IF I DO NOT FINISH THIS STUDY? 
It is your choice to be in this study or to stop at any time.  If you decide to stop 
being in this study, it is OK, but you must call the study doctor or the study 
coordinator.  If you stop being in the study, there will not be a penalty or loss 
of benefits to which you are otherwise entitled.  
 
10) WILL THERE BE ANY COSTS TO ME? 
It will not cost you anything to be in this study.  Your parking will be paid for while you 
are in this study. 
 
11)  HOW WILL MY STUDY INFORMATION BE KEPT PRIVATE? 
 
 Information collected for this study will be kept confidential to the extent allowed by 
law.  Each participant will be assigned a participation identification code.  Information 
used and/or disclosed (shared with someone outside of Children’s Hospital) may 
include information that can identify you.  This is called “protected health information” 
or PHI.  By agreeing to be in this study, you are giving permission or authorizing Dr. 
Brady Reynolds and his study staff to collect, use, and disclose your PHI for this 
research study.  Information collected is the property of Dr. Brady Reynolds.  In the 
event of any publication regarding this study, your child’s identity will not be revealed.   
Employees from the following organizations may receive copies of the study records: 
   
• Dr. Brady Reynolds and his employees 
• The Office for Human Research Protections (OHRP) 
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• The Institutional Review Board (IRB) of Children’s Research Institute (a 
committee that reviews all research) 
 
Because of the need to give information to these people, absolute confidentiality 
cannot be guaranteed.  Information given to these people may no longer be protected 
by federal privacy rules. 
 
• Protected Health Information that may be used or disclosed: 
 
o Breath – and urine-sample results 
o Self reports of recent drug use 
o All data generated from the questionnaires completed during 
participation 
o All data generated from the behavioral tasks completed during 
participation 
o All demographic data (for example, age, sex, race) collected during 
participation 
 
If you have a bad outcome or adverse event from being in this study, the Study 
Director and staff or other health care providers may need to look at your entire 
medical records. 
 
The PHI collected or created under this research study will be used/disclosed as 
needed until the end of the study.  The records of this study will be kept for an 
indefinite period of time. 
 
You may decide not to authorize the use and disclosure of your PHI, however, if it is 
required for this study, you will not be able to be in this study.  If you agree to be in this 
study and later decide to withdraw, you may also withdraw your authorization to use 
your PHI.  This request must be made in writing to the Study Director.  If you withdraw 
your authorization, no new PHI may be collected and the PHI already collected may 
not be used unless it has already been used or is needed to complete the study 
analysis and reports. 
 
To help us protect your privacy, we have obtained a Certificate of Confidentiality from 
the National Institutes of Health. With this Certificate, the researchers cannot be 
forced to disclose information that may identify you, even by a court subpoena, in 
any federal, state, or local civil, criminal, administrative, legislative, or other 
proceedings. The researchers will use the Certificate to resist any demands for 
information that would identify you, except as explained below. 
The Certificate cannot be used to resist a demand for information from personnel of 
the United States Government that is used for auditing or evaluation of Federally 
funded projects or for information that must be disclosed in order to meet the 
requirements of the federal Food and Drug Administration (FDA). 
You should understand that a Certificate of Confidentiality does not prevent you or a 
member of your family from voluntarily releasing information about yourself or your 
involvement in this research. If an insurer, employer, or other person obtains your 
written consent to receive research information, then the researchers may not use 
the Certificate to withhold that information. 
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The Certificate of Confidentiality does not prevent the researchers from disclosing 
voluntarily, without your consent, information that would identify you as a participant 
in the research project under the following circumstances:  
         -intent to cause injury to oneself. 
 
 
 
 
Dr. Brady Reynolds keeps a database of all subjects who participate in a research 
study.  This database is used to keep track of the research studies Dr. Reynolds 
conducts and who participated in each study.  This database is also used to contact 
people about future studies.   Only Dr. Reynolds and his staff have access to this 
database. 
 
Please initial: 
 
 
____  I want to be contacted about future research studies. 
 
____  I do not want to be contacted about future research studies. 
 
 
 
12)  WHOM SHOULD I CALL IF I HAVE QUESTIONS OR PROBLEMS? 
 
If you have questions about anything while on this study, you have 24 hour access to 
talk to your study doctor at 614-722-3549. If you have questions or are worried about 
your rights as a research volunteer, please call (614) 722-2708, Children's Hospital, 
Institutional Review Board, (IRB, a committee that reviews all research in humans at 
Children’s Hospital). 
 
Subject’s Name _________________________________ Date of 
Birth____________________ 
 
 
SUBJECT or SUBJECT’S LEGAL REPRESENTATIVE STATEMENT 
 
I have read this consent form and have had a chance to ask questions about this research 
study.  These questions have been answered to my satisfaction.  If I have more questions 
about participation in this study or a research-related injury, I may contact the Study 
Doctor.  By signing this consent form, I certify that all health information I have given is 
true and correct to the best of my knowledge. 
 
 
I agree to participate in this study and to allowing my child to participate in this study.  I will 
be given a copy of this consent form with all the signatures for my own records.   
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CONSENT SIGNATURES 
 
 
_____ ____________   
SUBJECT or SUBJECT’S LEGAL REPRESENTATIVE           DATE  SIGNED 
 
 
 
     
SUBJECT or SUBJECT’S LEGAL REPRESENTATIVE           DATE  SIGNED 
 
 
 
 
        
PERSON OBTAINING  CONSENT                                            DATE  SIGNED 
I certify that I have explained the research, 
it’s purposes, 
and the procedures to the subject or 
subject’s legal  
representative before requesting their 
signature. 
 
 
 
    
STUDY INVESTIGATOR   DATE  
SIGNED 
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Assent Form 
 
THE PERSON IN CHARGE OF THIS STUDY: Dr. Brady Reynolds 
   
Other Study Doctors: None 
 
 
SUBJECT’S NAME: ________________________  DATE OF BIRTH: 
____________ 
 
 
 
We invite you to be in a research study at Children’s Hospital.  We want you to 
read and understand some things about being in this research study:  
 
• It’s o.k. to say “no” if you don’t want to be in the study.  
• You are allowed to quit being in the study any time.  
• We have to explain the study to you so you can understand it. You can ask questions.  
 
1. WHY ARE WE DOING THIS RESEARCH STUDY? 
 
We are doing this research to help us better understand risk factors related to 
cigarette smoking status in teens. 
 
2. WHAT WILL HAPPEN DURING THE STUDY? 
The study will take place with one visit to Children’s Hospital which will take about 
2 to 2.5 hours. During this visit you will complete 13 questionnaires, 5 computer 
tasks, 2 face-to-face interviews, and complete a learning, thinking and problem-
solving task. You will also be asked to provide a breath and urine sample. These 
samples will be used to test for cigarette smoking only.   
 
When you arrive, you will start the session by giving a breath and urine sample. 
Then you will complete a learning, thinking, and problem-solving task that take 
about 30 minutes to complete. After this you will take a 5 minute break.  Then you 
will spend about 35 minutes completing paper and pencil questionnaires. Some of 
these questionnaires ask questions about teens’ attitudes of cigarette smoking. 
Others ask questions about potentially illegal activities. When you are finished with 
these, you will take another 5 minute break. After the break you will complete a 
group of computer tasks that will take about one hour. These computer tasks will 
give you the opportunity to earn money based on the choices you make while doing 
the tasks. You will get to keep the money you get from these tasks.  
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If you decide to quit the study before finishing the computer tasks, you will get to 
keep whatever amount of money you had earned up to that point 
 
 
Participation events for you:  
 
Session activities (2-2.5 hours): 
 
Child: 
8. Give urine and breath samples (about 5 minutes). 
9. Complete learning, thinking and problem-solving task (about 30 minutes). 
10. Break (about 5 minutes). 
11. Complete paper questionnaires (about 35 minutes). 
12. Break (about 5 minutes). 
13. Complete computer tasks (about 1 hour). 
14. Reimbursement. 
 
3. WHAT IF YOU DON’T WANT TO BE IN THE STUDY? 
 
You can say “no” to being in the study if you want. You can also drop out of the 
study anytime  
you want.  
 
4. WHAT ELSE DO I NEED TO KNOW? 
 
Sometimes doctors write papers about research studies when they are done. 
If a paper is written about this research study, your name won’t be used in it. 
We will keep your information private. People who work for Children’s 
Research Institute, the study sponsor, and government agencies will be able 
to look at your medical information.  All information collected during the 
sessions will be kept private.  No information collected will be shared with 
parents.  
 
There is no cost to you or your parents to be in this study. You will be 
compensated for the amount of time you spend and any discomforts you may 
have while participating in this study. 
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I have read this form.  I have had a chance to ask questions about things I don’t understand.  I 
want to be in this research study and understand what will happen to me.   
 
 
___________________________________  ___________  
Signature of the
 
 Subject    Date 
__________________________________  ___________ 
__________________________________  ____________ 
 you have questions about the study, you can call Dr. Brady Reynolds or a member of the study 
 
_
Signature of the Person Obtaining Assent  Date 
 
_
Signature of the Principal Investigator  Date 
 
 
If
staff at (614) 722-3549. 
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Appendix B 
 
Demographic Questions 
 
1. What is your age:  
2. Sex:   Male        Female 
3. Grade/Level in School:  
4. Race:    Black        White         Asian         Hispanic         Native American      Other 
5. How many siblings (brothers or sisters) do you have:  (circle one)  
       1          2          3          4          5       Other                  
6. If you have siblings, what are their ages:                                                                                     
7. What class grade do you typically get:    A      B      C      D      F     (circle one)        
                        
 
8. How many of your friends smoke cigarettes? (Please circle one of the options 
below) 
 
          None          Some          Half            Most             All 
 
 
9. How many of your male friends smoke cigarettes?  
(Please circle one of the options below) 
 
          None          Some          Half            Most             All 
 
10. How many of your female friends smoke cigarettes?  
(Please circle one of the options below) 
 
          None          Some          Half            Most             All 
 
11. How many of your siblings (from question 5) smoke cigarettes:                            
 
12. Does your mother smoke?    (circle YES or NO) 
 
13. Does your father smoke?    (circle YES or NO) 
 
14. Do any other caregivers smoke?    (circle YES or NO)  
           If yes, which caregiver?  For example stepfather, stepmother:   
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            15. Not counting caregivers and siblings, how many members of your extended 
family (aunts, uncles, grandparents) smoke cigarettes?  (Please circle one of the 
options below) 
                      
         None          Some           Half             Most             All 
 
 
16. Does your closest or best friend smoke cigarettes?    (circle YES or NO) 
 
17. Do you currently use any form of smokeless tobacco?    (circle YES or NO) 
 
18. Do you currently smoke cigarettes?   (circle YES or NO) 
 
 
 
 
FOR THIS STUDY 
 
19. You will have the potential to earn between $20 and $30 in this study. For you, 
how important is it that you earn as close to $30 as possible? (Please circle from 1 to 
10 below) 
          Not                                                                                                  Extremely 
    Important                                                                                            Important 
 
             1          2          3          4          5          6          7          8          9          10 
 
 
 
 
ANSWER QUESTIONS 20 THROUGH 23 ONLY IF YOU SMOKE REGULARLY NOW 
 
20. For how long have you smoked cigarettes?  
 
21. On average, how many cigarettes do you smoke a week?  
 
22. When was your last cigarette?  
 a. 1-20 minutes ago 
 b. 21-30 minutes ago 
 c. 31-45 minutes ago 
 d. 46-60 minutes ago 
 e. more than 60 minutes ago 
 
23. Do you want to quit?  
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Appendix C 
 
BIS-11-A 
Directions: 
People differ in the ways they act and think in different situations. This is a test to 
measure some of the ways in which you act and think. Read each statement carefully and 
CIRCLE THE APPROPRIATE NUMBER to the right of the statement. Answer 
quickly and honestly.     
 
                                                               Rarely/        Occasionally         Often          Almost always/ 
                                                                            Never                                                                       Always 
 
1. I plan what I have to do. .  . . . . . .   1                      2                    3                      4 
2. I do things without thinking. . . . .  1                      2                    3                      4 
3. I make up my mind quickly. . . . .  1                      2                    3                      4 
4. I am happy-go-lucky. . . . . . . . . . .  1                      2                    3                      4 
5. I do not “pay attention”. . . . . . . .  1                      2                    3                      4 
6. My thoughts are racing too fast. . 1                      2                    3                      4 
7. I plan my spare time. . . . . . . . . . .  1                      2                    3                      4 
8. I am self controlled. . . . . . . . . . . .  1                      2                    3                      4 
9. I concentrate easily. . . . . . . . . . . .  1                      2                    3                      4 
10. I am a “saver”. . . . . . . . . . . . . . . .  1                      2                    3                      4 
11. I cannot stand still at movies or  
       school. . . . . . . . . . . . . . . . . . . . . . .  1                      2                    3                      4 
12. I like to think carefully about  
       things. . . . . . . . . . . . . . . . . . . . . . .  1                      2                    3                      4 
13.    I plan for my future. . . . . . . . . . . .  1                      2                    3                      4 
14.    I say things without thinking. . . . .  1                      2                    3                      4  
15.    I like to think about complex  
          problems. . . . . . . . . . . . . . . . . . . . . 1                      2                    3                      4 
16. I change my mind about what I  
 will do when I grow up. . . . . . . . .  1                      2                    3                      4  
17. I act “on impulse”. . . . . . . . . . . . . .1                      2                    3                      4 
18. I get easily board when solving  
 thought problems. . . . . . . . . . . . . .     1                      2                    3                      4 
19. I act on the spur of the moment. . . 1                      2                    3                      4 
20. I am a great thinker. . . . . . . . . . . . . 1                      2                    3                      4 
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                                                             Rarely/        Occasionally        Often            Almost always/ 
                                                                           Never                                                                       Always 
 
21. I change friends. . . . . . . . . . . . . . . .  1                      2                    3                      4 
22. I buy things on impulse. . . . . . . . . . 1                      2                    3                      4 
23. I can think about one  
 problem at a time. . . . . . . . . . . . .        1                     2                    3                      4   
24. I change hobbies and sports. . . . .  1                     2                    3                      4 
25. I spend more than I should. . . . . .  1                     2                    3                      4 
26. When I think about something, 
other thoughts pop up in my mind       1                     2                    3                      4 
27. I am more interested in the  
present than in the future. . . . . . . .        1                     2                    3                      4 
28. I am restless at the movies or 
lectures. . . . . . . . . . . . . . . . . . . . . . .       1                     2                    3                      4  
29. I like to play chess or checkers. . . . 1                     2                    3                      4 
30. I am future oriented. . . . . . . . . . . . . 1                     2                    3                      4 
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Appendix D 
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Appendix E 
Delay discounting questionnaire (DDQ) 
 
[Say] 
“You will be choosing between different amounts of money available after different 
delays.  There are no right or wrong answers to these questions… just pick what you 
prefer.  But, the questions you answer are important because one of your answers will be 
selected at random and you will get what you chose.  If you chose delayed money, the 
money will be put in an envelope with your name and address on it, and it will be mailed 
to you after the delay.  For example, if you chose $10 in 180 days from now, the $10 will 
be mailed to you after the delay.  For example, if you chose $10 in 180 days from now, 
the $10 will be mailed to you in $180 days. 
In other words….. you’re choosing between two options that are presented on the screen.  
There’s no right or wrong answers so pick what you prefer.  At the end, one of the 
questions will be picked and you will get what you chose.  So if you chose $10 in 2 days, 
that money will be mailed to you in 2 days.  If you chose $3 now, that money will be 
added into your total earnings for today.” 
“Any questions?” 
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Appendix F 
GoStop Task 
1. For this task you need to pay attention and remember numbers.  This card shows 
you what the computer screen will look like during your session.  Like you see on 
the card here, the numbers will be black against a white background.  The three-
digit numbers appear on the screen one right after another. 
2. If the numbers match, like this one matches the number you just saw… then you 
should click the left mouse button, but ONLY when the number you see is exactly 
the same as the one just before it.  Each correct response earns you money. 
3. If the numbers do not match, like this one doesn’t match the last one, then do not 
click the left mouse button.  If you click a non-matching number you lose money. 
4. Ok…. This is the important part.  Whenever you respond (by clicking) to a 
number, you must click while that number is still on the screen.  Clicking after the 
number disappears from the screen does not count and you will lose money. 
5. Another tricky part is that sometimes a number that matches the one you just saw 
will change from black to red.  Do NOT click on any number that changes to red.  
If you click on a number that changes to red, you lose money. 
6. During your session you will have a short rest break.  The screen will show you a 
message that tells you how much money you’ve earned and how much you’ve 
lost up to that point.  It will also say “Please Rest” …during this time just sit and 
rest. 
7. Just before the end of the break a message will tell you to “get ready.”  When you 
see this message, watch the screen for the next part of the session to start. You 
will do the same thing during all parts of the session…clicking won the matching 
numbers while they are still on the screen, as long as they don’t turn red 
8. You will be paid for this session based on how accurately you perform… clicking 
the mouse when you’re supposed to and NOT clicking when you’re not supposed 
to.  When the session is over a box will come up again telling you “Please Rest.”  
Shortly after this, another box will pop up telling you how much you’ve earned 
and how much you’ve lost during your session. 
9. Do you have any questions? 
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Appendix G 
Timeline Followback Directions 
 
Prior to the interview: 
 
1) Select the calendars you’ll need (if you are doing an interview on 
December 10 you will need the calendars for November and 
December). 
2) The assessment window is 30 days long.  It begins the day prior to the 
appointment date (count this as day 1) and goes back 29 more days (to 
day 30).  Highlight the beginning and ending dates. 
 
Data collection objectives: 
 
1) For each day of the 30 day window record the # of cigarettes 
(including bidis, kreteks, clove cigarettes) per day on the appropriate 
line.   
2) Circle a Y (yes) or N (no) for report of quit attempts. 
 
Interview: 
 
“Now we are going to begin the questionnaire part of the project.  I want 
to remind you that the information that you provide will not be shared 
with anyone outside of the project’s staff.  I ask that you be as honest as 
you can when answering these questions.  Ask me any questions you may 
have as we go through the questionnaires. 
 
“I am going to ask you to recall the number of cigarettes, bidis and flavored 
cigarettes you have smoked in the last 30 days, starting with yesterday.  I just 
want to get an idea of how many cigarettes you have smoked per day during this 
time period.  This is not a difficult task, especially when you use this calendar and 
work your way back each day. I realize that it’s hard to recall with 100 % 
accuracy, but just try to be as accurate as possible.  When you are unsure, give it 
your best guess.  The important thing is that you provide your best estimate for 
each day.” 
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TIMELINE FOLLOW BACK 
Month ________ , Year ________       ID# ________ 
 
 
Sunday Monday Tuesday Wednesday Thursday Friday Saturday 
   Day # ___ 
 
___# cigarettes 
   
  if 0 cigarettes, 
    Quit?   
 Y    N 
 
Day # ___ 
 
___# cigarettes 
    
 if 0 cigarettes, 
    Quit?   
 Y    N 
Day # ___ 
 
___# cigarettes 
   
  if 0 cigarettes, 
    Quit?   
 Y    N 
Day # ___ 
 
___# cigarettes 
   
  if 0 cigarettes, 
    Quit?   
 Y    N 
Day # ___ 
 
___# cigarettes 
   
  if 0 cigarettes, 
    Quit?    
Y    N 
Day # ___ 
 
 ___# cigarettes
   
  if 0 cigarettes, 
    Quit?   
 Y    N 
Day # ___ 
 
___# cigarettes 
    
 if 0 cigarettes, 
    Quit?   
 Y    N 
 
Day # ___ 
 
___# cigarettes 
    
 if 0 cigarettes, 
    Quit?   
 Y    N 
 
Day # ___ 
 
___# cigarettes 
   
  if 0 cigarettes, 
    Quit?    
Y    N 
 
Day # ___ 
 
___# cigarettes 
   
  if 0 cigarettes, 
    Quit?   
 Y    N 
 
Day # ___ 
 
___# cigarettes 
   
  if 0 cigarettes, 
    Quit?   
Y    N 
 
Day # ___ 
 
___# cigarettes 
    
 if 0 cigarettes, 
    Quit?   
 Y    N 
 
Day # ___ 
 
___# cigarettes 
    
 if 0 cigarettes, 
    Quit?   
 Y    N 
 
 Day # ___ 
 
___# cigarettes 
    
 if 0 cigarettes, 
    Quit?    
Y    N 
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Appendix H 
Substance-Use Questionnaire 
 
Thinking about the past six months, how often have you used the following substances?
 
       Never    Tried             1-2x/          Once a          2-4x/          5 or more x/ 
                                                    Tried         it               month          week            week                week 
 
ALCOHOL 
(Beer /mixed drinks/etc.)               0       1                    2                 3                    4                      5 
 
MARIJUANA 
(Pot/grass/hashish)  0        1                    2                 3                    4                      5 
   
CLUB DRUGS 
(Ecstasy, GHB, Ketamne) 0          1                    2                 3                    4                      5 
  
OPIATES 
(Heroin/morphine/ 
  demorol/codine) 0        1                    2                 3                    4                      5 
 
CAFFEINE 0        1                    2                 3                    4                      5 
 
BARBITURATES 
(Downers/sleeping pills) 0        1                    2                 3                    4                      5 
 
CIGARETTES 0        1                    2                 3                    4                      5 
 
TRANQUILIZERS 
(Valium, Librium) 0        1                    2                 3                    4                      5 
 
COCAINE, CRACK 0        1                    2                 3                    4                      5 
 
AMPHETAMINES 
(Uppers/speed) 0        1                    2                 3                    4                      5 
 
CRYSTAL METH 
(Ice/crystal) 0        1                    2                 3                    4                      5 
 
RITALIN 0        1                    2                 3                    4                      5 
 
PSYCHEDELICS 
(LSD/Mescaline/peyote) 0        1                    2                 3                    4                      5 
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